About
Small Molecules, Injector
Areas of Focus
Categories
Drug Delivery DeviceSmall Molecule Pharmaceutical
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
29
As Collaborator
1
Total Enrollment
3,260
By Phase
PHASE2: 12PHASE1: 5PHASE3: 13
By Status
COMPLETED: 21TERMINATED: 3ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 2RECRUITING: 1NOT_YET_RECRUITING: 1
Clinical Trials Pipeline29 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07047404Lead Sponsor
Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation
PHASE2Recruiting
60 participants
Started: Sep 15, 2025 · Completed: Dec 31, 2026
NCT07074002Lead Sponsor
Proof of Concept Study on BP1.4979 Effect on Essential Tremor
PHASE2Not yet recruiting
50 participants
Started: Jul 31, 2025 · Completed: Dec 31, 2026
NCT05953389Lead Sponsor
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
PHASE2Active, not recruiting
62 participants
Started: Dec 20, 2023 · Completed: Nov 30, 2025
NCT05240560Lead Sponsor
Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke
PHASE2Terminated
5 participants
Started: Jan 20, 2023 · Completed: Feb 8, 2024
NCT05118906Lead Sponsor
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
PHASE2Active, not recruiting
66 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2025
Locations (1)
Headquarters
Paris, France
Map
Loading map...